Melanocortin 5 receptor signaling and internalization: Role of MAPK/ERK pathway and β-arrestins 1/2

Molecular and Cellular Endocrinology

Volumn 361, Issue 1-2, 2012, Pages 69-79

  Rodrigues, Adriana R ^a,b   Almeida, Henrique ^a,b   Gouveia, Alexandra M ^a,b,c  

^a University of Porto   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

Melanocortin receptors ERK1 2 G protein coupled receptor (GPCR) arrestins; arrestins; ERK1 2; G protein coupled receptor (GPCR); Melanocortin receptors

Indexed keywords

ALPHA INTERMEDIN; BETA ARRESTIN 1; BETA ARRESTIN 2; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MELANOCORTIN 5 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MSK1 PROTEIN; PROTEIN FOS; PROTEIN P90; S6 KINASE; UNCLASSIFIED DRUG;

ADIPOCYTE; ARTICLE; CELL NUCLEUS; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HELA CELL; HUMAN; HUMAN CELL; INTERNALIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; ARRESTINS; CYTOSOL; ENDOCYTOSIS; ENZYME ACTIVATION; GENE SILENCING; GENES, DOMINANT; GREEN FLUORESCENT PROTEINS; GTP-BINDING PROTEINS; HELA CELLS; HUMANS; MAP KINASE SIGNALING SYSTEM; MICE; PHOSPHORYLATION; RECEPTORS, MELANOCORTIN; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; RNA, SMALL INTERFERING; SUBCELLULAR FRACTIONS;

EID: 84864359242     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2012.03.011     Document Type: Article

References (46)

1. Ahn S., Shenoy S.K., Wei H., Lefkowitz R.J. Differential kinetic and spatial patterns of beta-arrestin and G protein-mediated ERK activation by the angiotensin II receptor. J. Biol. Chem. 2004, 279:35518-35525.
2. An J.J., Rhee Y., Kim S.H., Kim D.M., Han D.H., Hwang J.H., Jin Y.J., Cha B.S., Baik J.H., Lee W.T., Lim S.K. Peripheral effect of alpha-melanocyte-stimulating hormone on fatty acid oxidation in skeletal muscle. J. Biol. Chem. 2007, 282:2862-2870.
3. Basu S.K., Goldstein J.L., Anderson R.G., Brown M.S. Monensin interrupts the recycling of low density lipoprotein receptors in human fibroblasts. Cell 1981, 24:493-502.
4. Boston B.A., Cone R.D. Characterization of melanocortin receptor subtype expression in murine adipose tissues and in the 3T3-L1 cell line. Endocrinology 1996, 137:2043-2050.
5. Boston B.A. The role of melanocortins in adipocyte function. Ann. N.Y. Acad. Sci. 1999, 885:75-84.
6. Broca C., Quoyer J., Costes S., Linck N., Varrault A., Deffayet P.M., Bockaert J., Dalle S., Bertrand G. Beta-arrestin 1 is required for PAC1 receptor-mediated potentiation of long-lasting ERK1/2 activation by glucose in pancreatic beta-cells. J. Biol. Chem. 2009, 284:4332-4342.
7. Buch T.R., Heling D., Damm E., Gudermann T., Breit A. Pertussis toxin-sensitive signaling of melanocortin-4 receptors in hypothalamic GT1-7 cells defines agouti-related protein as a biased agonist. J. Biol. Chem. 2009, 284:26411-26420.
8. Buggy J.J. Binding of alpha-melanocyte-stimulating hormone to its G-protein-coupled receptor on B-lymphocytes activates the Jak/STAT pathway. Biochem. J. 1998, 331(Pt 1):211-216.
9. Cai M., Varga E.V., Stankova M., Mayorov A., Perry J.W., Yamamura H.I., Trivedi D., Hruby V.J. Cell signaling and trafficking of human melanocortin receptors in real time using two-photon fluorescence and confocal laser microscopy: differentiation of agonists and antagonists. Chem. Biol. Drug Des. 2006, 68:183-193.
10. Calebiro D., Nikolaev V.O., Persani L., Lohse M.J. Signaling by internalized G-protein-coupled receptors. Trends Pharmacol. Sci. 2010, 31:221-228.
11. Chai B., Li J.Y., Zhang W., Ammori J.B., Mulholland M.W. Melanocortin-3 receptor activates MAP kinase via PI3 kinase. Regul. Pept. 2007, 139:115-121.
12. Chan L.F., Webb T.R., Chung T.T., Meimaridou E., Cooray S.N., Guasti L., Chapple J.P., Egertova M., Elphick M.R., Cheetham M.E., Metherell L.A., Clark A.J. MRAP and MRAP2 are bidirectional regulators of the melanocortin receptor family. Proc. Nat. Acad. Sci. U.S.A. 2009, 106:6146-6151.
13. Chen W., Kelly M.A., Opitz-Araya X., Thomas R.E., Low M.J., Cone R.D. Exocrine gland dysfunction in MC5-R-deficient mice. Evidence for coordinated regulation of exocrine gland function by melanocortin peptides. Cell 1997, 91:789-798.
14. Cho K.J., Shim J.H., Cho M.C., Choe Y.K., Hong J.T., Moon D.C., Kim J.W., Yoon D.Y. Signaling pathways implicated in alpha-melanocyte stimulating hormone-induced lipolysis in 3T3-L1 adipocytes. J. Cell. Biochem. 2005, 96:869-878.
15. Cooray S.N., Clark A.J. Melanocortin receptors and their accessory proteins. Mol. Cell. Endocrinol. 2011, 331:215-221.
16. DeFea K.A. Beta-arrestins as regulators of signal termination and transduction: how do they determine what to scaffold?. Cell. Signalling 2011, 23:621-629.
17. Fernandez N., Monczor F., Baldi A., Davio C., Shayo C. Histamine H2 receptor trafficking: role of arrestin, dynamin, and clathrin in histamine H2 receptor internalization. Mol. Pharmacol. 2008, 74:1109-1118.
18. Fricke K., Heitland A., Maronde E. Cooperative activation of lipolysis by protein kinase A and protein kinase C pathways in 3T3-L1 adipocytes. Endocrinology 2004, 145:4940-4947.
19. Gesty-Palmer D., Chen M., Reiter E., Ahn S., Nelson C.D., Wang S., Eckhardt A.E., Cowan C.L., Spurney R.F., Luttrell L.M., Lefkowitz R.J. Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation. J. Biol. Chem. 2006, 281:10856-10864.
20. Goldsmith Z.G., Dhanasekaran D.N. G protein regulation of MAPK networks. Oncogene 2007, 26:3122-3142.
21. Gong K., Li Z., Xu M., Du J., Lv Z., Zhang Y. A novel protein kinase A-independent, beta-arrestin-1-dependent signaling pathway for p38 mitogen-activated protein kinase activation by beta2-adrenergic receptors. J. Biol. Chem. 2008, 283:29028-29036.
22. Hansen S.H., Sandvig K., van Deurs B. Clathrin and HA2 adaptors: effects of potassium depletion, hypertonic medium, and cytosol acidification. J. Cell Biol. 1993, 121:61-72.
23. Hauge C., Frodin M. RSK and MSK in MAP kinase signalling. J. Cell Sci. 2006, 119:3021-3023.
24. Heuser J.E., Anderson R.G. Hypertonic media inhibit receptor-mediated endocytosis by blocking clathrin-coated pit formation. J. Cell Biol. 1989, 108:389-400.
25. Herraiz C., Journe F., Abdel-Malek Z., Ghanem G., Jimenez-Cervantes C., Garcia-Borron J.C. Signaling from the human melanocortin 1 receptor to ERK1 and ERK2 mitogen-activated protein kinases involves transactivation of cKIT. Mol. Endocrinol. 2011, 25:138-156.
26. Hoogduijn M.J., McGurk S., Smit N.P., Nibbering P.H., Ancans J., van der Laarse A., Thody A.J. Ligand-dependent activation of the melanocortin 5 receptor: cAMP production and ryanodine receptor-dependent elevations of [Ca(2+)](I). Biochem. Biophys. Res. Commun. 2002, 290:844-850.
27. Jean-Alphonse F., Hanyaloglu A.C. Regulation of GPCR signal networks via membrane trafficking. Mol. Cell. Endocrinol. 2011, 331:205-214.
28. Kondoh K., Torii S., Nishida E. Control of MAP kinase signaling to the nucleus. Chromosoma 2005, 114:86-91.
29. Larkin J.M., Donzell W.C., Anderson R.G. Potassium-dependent assembly of coated pits: new coated pits form as planar clathrin lattices. J. Cell Biol. 1986, 103:2619-2627.
30. Lefkowitz R.J., Shenoy S.K. Transduction of receptor signals by beta-arrestins. Science 2005, 308:512-517.
31. Lin J.H., Wang H.Y., Fong J.C., Pan J.T., Wang F.F. Correlation between prolactin secretion and Gs protein expression during sustained cholera-toxin stimulation. Biochem. J. 1993, 296:335-340.
32. Luo J., Busillo J.M., Benovic J.L. M3 muscarinic acetylcholine receptor-mediated signaling is regulated by distinct mechanisms. Mol. Pharmacol. 2008, 74:338-347.
33. Mizuno K., Kanda Y., Kuroki Y., Nishio M., Watanabe Y. Stimulation of beta(3)-adrenoceptors causes phosphorylation of p38 mitogen-activated protein kinase via a stimulatory G protein-dependent pathway in 3T3-L1 adipocytes. Br. J. Pharmacol. 2002, 135(4):951-960.
34. Mollenhauer H.H., Morre D.J., Rowe L.D. Alteration of intracellular traffic by monensin; mechanism, specificity and relationship to toxicity. Biochim. Biophys. Acta 1990, 1031:225-246.
35. Moller C.L., Raun K., Jacobsen M.L., Pedersen T.A., Holst B., Conde-Frieboes K.W., Wulff B.S. Characterization of murine melanocortin receptors mediating adipocyte lipolysis and examination of signalling pathways involved. Mol. Cell. Endocrinol. 2011.
36. Mountjoy K.G. Functions for pro-opiomelanocortin-derived peptides in obesity and diabetes. Biochem. J. 2010, 428:305-324.
37. Mountjoy K.G., Kong P.L., Taylor J.A., Willard D.H., Wilkison W.O. Melanocortin receptor-mediated mobilization of intracellular free calcium in HEK293 cells. Physiol. Genomics 2001, 5:11-19.
38. Murphy L.O., Smith S., Chen R.H., Fingar D.C., Blenis J. Molecular interpretation of ERK signal duration by immediate early gene products. Nat. Cell Biol. 2002, 4:556-564.
39. Nishihara H., Hwang M., Kizaka-Kondoh S., Eckmann L., Insel P.A. Cyclic AMP promotes cAMP-responsive element-binding protein-dependent induction of cellular inhibitor of apoptosis protein-2 and suppresses apoptosis of colon cancer cells through ERK1/2 and p38 MAPK. J. Biol. Chem. 2004, 279:26176-26183.
40. Norman D., Isidori A.M., Frajese V., Caprio M., Chew S.L., Grossman A.B., Clark A.J., Michael Besser G., Fabbri A. ACTH and alpha-MSH inhibit leptin expression and secretion in 3T3-L1 adipocytes: model for a central-peripheral melanocortin-leptin pathway. Mol. Cell. Endocrinol. 2003, 200:99-109.
41. Pellegrino M.J., Stork P.J. Sustained activation of extracellular signal-regulated kinase by nerve growth factor regulates c-fos protein stabilization and transactivation in PC12 cells. J. Neurochem. 2006, 99:1480-1493.
42. Rodrigues A.R., Pignatelli D., Almeida H., Gouveia A.M. Melanocortin 5 receptor activates ERK1/2 through a PI3K-regulated signaling mechanism. Mol. Cell Endocrinol. 2009, 303:74-81.
43. Sebag J.A., Hinkle P.M. Opposite effects of the melanocortin-2 (MC2) receptor accessory protein MRAP on MC2 and MC5 receptor dimerization and trafficking. J. Biol. Chem. 2009, 284:22641-22648.
44. Shenoy S.K., Drake M.T., Nelson C.D., Houtz D.A., Xiao K., Madabushi S., Reiter E., Premont R.T., Lichtarge O., Lefkowitz R.J. Beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor. J. Biol. Chem. 2006, 281:1261-1273.
45. Vercauteren D., Vandenbroucke R.E., Jones A.T., Rejman J., Demeester J., De Smedt S.C., Sanders N.N., Braeckmans K. The use of inhibitors to study endocytic pathways of gene carriers: optimization and pitfalls. Mol. Ther. 2010, 18:561-569.
46. Woehler A., Ponimaskin E.G. G protein-mediated signaling: same receptor, multiple effectors. Curr. Mol. Pharmacol. 2009, 2:237-248.